510(k) Report

510(k) · Cleared

Cleared

Bio-Rad Coda Neonatal Galt Assay

K993536510(k) SpecialCleared Nov 4, 199916-day reviewClass II21 CFR 862.1315

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad · KQP Fluorescent Proc. (Qual.), Galactose-1-Phosphate Uridyl Transferase

Cleared on Nov 4, 1999 as substantially equivalent to K990827 (Bio-Rad, 1999) and 1 other predicate after a 16-day review. Its family tree reaches back 2 generations to 1996.

Decided
Nov 4, 1999
Review
16 days
Class
Class II
Product code
KQP
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K961432 (1996). No later device cites it as a predicate yet.

  1. Root · 2 generations backK961432 Radias Galt TestBio-Rad · 1996
  2. 1 generation backK990827 Microplate Neonatal Galt AssayBio-Rad · 1999
  3. This deviceK993536 Bio-Rad Coda Neonatal Galt AssayBio-Rad · 1999
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K961432Radias Galt TestBio-Rad1996—
−1K990827Microplate Neonatal Galt AssayBio-Rad1999—
0 (this device)K993536Bio-Rad Coda Neonatal Galt AssayBio-Rad1999—
FIG. 1 — Lineage of K993536, 1996–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KQP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K990827Microplate Neonatal Galt Assay
Our OCR of the scanned summary read K998027, which is not a number in FDA’s lists. Corrected to the number with two digits swapped whose FDA name carries the summary’s words for the device, “Microplate Neonatal GALT Assay”.
Bio-Rad1999—
*K961432Radias Galt Test
Summary page 1
…o-Rad CODA Neonatal GALT Assay Galactose-1-phosphate uridyl transferase test system Microplate Neonatal GALT Assay K998027 Bio-Rad Laboratories, Inc. RADIAS GALT Assay K961432 Bio-Rad Laboratories, Inc. This assay is for the qualitative determination of galactose- 1-phosphate uridyl transferase activity…
Bio-Rad1996—

Also cleared against K990827: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 3 years and passes through 1 company; a new generation was cleared every 2.4 years on median.
  • None of the 2 ancestors has a recall.
  • 2 other devices also cite its predicate K990827.

How does its category compare?

All KQP devices

KQP Fluorescent Proc. (Qual.), Galactose-1-Phosphate Uridyl Transferase: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KQP

2in 2011

2010: 12011: 2
2007high 2 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KQP

Too few KQP 510(k)s in any year since 2007 to give a median.

Recalls per year · KQP

1so far in 2026, the most since 2007

2026 (partial year): 1
2007high 1 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KQP

No MAUDE report names KQP since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20101—00
20112—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—1—

What is it indicated for?

This assay is for the qualitative determination of galactose-1-phosphate uridyl transferase activity in dried blood spot samples using the Bio-Rad CODA Analyzer. Measurements of GALT are used in the diagnosis and treatment of the hereditary disease galactosemia (disorder of galactose metabolism) in infants.

For in vitro diagnostic use only.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K993536: Bio-Rad Coda Neonatal Galt Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K993536

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026